Top in GI: Dietary factors in colorectal cancer, delayed-release linaclotide

A recent study found that dietary factors, including fiber and alcohol intake, were associated with the development or prevention of colorectal cancer. It was the top story in gastroenterology last week.

Other top stories include new data on a delayed-release version of linaclotide for patients with constipation-predominant irritable bowel syndrome, and an in-depth look at social media use in the field of gastroenterology.

Read these and more top stories in gastroenterology below:

Dietary factors may have role in development of CRC

Researchers said they found convincing evidence demonstrating an association between red meat and alcohol intake and colorectal cancer incidence. Read more.

Delayed-release linaclotide improves abdominal pain in IBS-C

Patients with constipation-predominant irritable bowel syndrome treated with a delayed-release version of linaclotide experienced improvements in abdominal pain, according to study results. Read more.

GI Twitter: Using social media to engage with the GI community

Engagement with social media has become a huge part of society, especially in health care, according to a report published in Gastroenterology. Read more.

GIs should educate patients about safety, effectiveness of COVID vaccines

Gastroenterologists should feel comfortable educating patients that appropriate steps are being taken to ensure the COVID-19 vaccine is safe and effective, according to a report published in Clinical Gastroenterology and Hepatology. Read more.

VIDEO: Text message program offers support to patients diagnosed with CRC

In an exclusive video, Healio Gastroenterology spoke with Brian Dooreck, MD, of Gastrointestinal Diagnostic Centers in Pembroke Pines, Fla., about the colorectal cancer provider outreach program, or CRC POP. Read more.